Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  idelalisib
Find trials that include:  Any drugs shown
Results 1-8 of 8 for your search:
Start Over
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GS-US-313-0124, NCI-2013-01738, NCT01732913
Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Age: 65 and over
Trial IDs: GS-US-312-0118, NCI-2015-01760, 2013-004551-20, NCT01980875
Dose Optimization Study of Idelalisib in Follicular Lymphoma and Small Lymphocytic Lymphoma
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: GS-US-313-1580, NCI-2015-01816, 2015-000366-66, NCT02536300
Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: GS-US-312-1579, NCI-2015-01964, NCT02538614
Idelalisib and Ofatumumab in Treating Patients with Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-309, NCI-2014-01554, IN-US-312-1237, NCT02135133
Idelalisib in Treating Patients with Relapsed or Refractory Waldenstrom Macroglobulinemia
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 15-040, NCI-2015-01605, NCT02439138
Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: GS-US-385-1577, NCI-2015-01035, NCT02468557
Start Over